UNIQUE C-CODE FOR GAZYVA

28 Mar 2014 9:34 AM | Lori Aubrey (Administrator)
UNIQUE C-CODE FOR GAZYVA
The Centers for Medicare & Medicaid Services (CMS) has granted a unique C-code for GAZYVA™ (obinutuzumab). The C-code for GAZYVA is C9021 (injection, obinutuzumab, 10 mg). The C-code goes into effect on April 1, 2014, and should be used until a permanent J-code is assigned. If granted, the permanent J-code is expected to be available for use starting January 1, 2015.

Code Updates

Comments

Northern New England Clinical Oncology Society
P.O. Box 643
Sandown, NH 03873-0643
Telephone (603) 887-1948
info@nnecos.org

This website brought to you by:


Powered by Wild Apricot Membership Software